Contineum Therapeutics Inc. (CTNM)
CTNM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.42
-1.69% on the day
Market cap
$316.8M
Small cap
Revenue · 2024
$0
-100.0% on 2023
Net income · 2024
-$42.3M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | CTNM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001855175 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$42.3M |
| Operating income | -$50.9M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | -100.0% |
| Cash | $21.9M |
| Total assets | $212.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-03-05 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 194 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -37.1% |
| 1 month | -42.1% |
| 3 months | -42.9% |
| Year to date | -30.0% |
| 1 year | -32.9% |
| From 52-week high | -54.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TTRX | Turn Therapeutics Inc. | $10.60 | -4.59% | $315.8M |
| INDP | Indaptus Therapeutics Inc. | $2.39 | -2.05% | $318.4M |
| CYPH | Cypherpunk Technologies Inc. | $2.84 | -2.07% | $306.1M |
| BNTC | Benitec Biopharma Inc. | $8.63 | -4.85% | $301.0M |
| ENTA | Enanta Pharmaceuticals Inc. | $11.52 | -6.34% | $335.5M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $12.03 | -4.60% | $341.9M |
| IRD | Opus Genetics Inc. | $4.24 | -8.62% | $352.8M |
| PRLD | Prelude Therapeutics Incorporated | $3.56 | -4.81% | $284.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier